Tudor Investment Corp’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-111,385
Closed -$18.4M – 2984
2021
Q2
$18.4M Buy
111,385
+4,081
+4% +$681K 0.35% 35
2021
Q1
$16.5M Buy
+107,304
New +$14.6M 0.33% 41
2020
Q2
– Sell
-4,065
Closed -$338K – 1514
2020
Q1
$338K Sell
4,065
-9,585
-70% -$935K 0.03% 643
2019
Q4
$1.52M Sell
13,650
-898
-6% -$92.4K 0.07% 385
2019
Q3
$1.44M Buy
14,548
+7,354
+102% +$730K 0.05% 396
2019
Q2
$713K Buy
+7,194
New +$687K 0.02% 598
2017
Q4
– Sell
-8,397
Closed -$640K – 1359
2017
Q3
$640K Sell
8,397
-6,070
-42% -$459K 0.02% 560
2017
Q2
$1.08M Buy
14,467
+4,056
+39% +$281K 0.03% 318
2017
Q1
$679K Sell
10,411
-19,309
-65% -$1.14M 0.02% 541
2016
Q4
$1.64M Sell
29,720
-5,773
-16% -$317K 0.04% 217
2016
Q3
$2.01M Sell
35,493
-8,437
-19% -$414K 0.05% 210
2016
Q2
$1.83M Buy
43,930
+7,229
+20% +$333K 0.04% 245
2016
Q1
$1.57M Buy
36,701
+15,454
+73% +$653K 0.04% 336
2015
Q4
$962K Buy
21,247
+401
+2% +$16.8K 0.03% 477
2015
Q3
$809K Buy
20,846
+12,705
+156% +$509K 0.03% 488
2015
Q2
$296K Buy
+8,141
New +$258K 0.01% 1113

Other funds holding PRAH

Tudor Investment Corp's PRAH Position: Q3 2021 in Review

Tudor Investment Corp sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 111,385 shares — an estimated $18.4M sold.

Tudor Investment Corp first reported a position in PRAH in Q2 2015 and held it in 16 quarters. The position peaked at $18.4M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Tudor Investment Corp reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 111,385 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $18.4M.
  • Tudor Investment Corp first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 16 quarters.
  • Tudor Investment Corp's PRA Health Sciences, Inc. position peaked at $18.4M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.